These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 16723109

  • 21. Development of single-agent chemotherapy regimens for gestational trophoblastic disease.
    Homesley HD.
    J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517
    [Abstract] [Full Text] [Related]

  • 22. Methotrexate on a 21-day cycle for low-risk gestational trophoblastic neoplasia.
    Diaz J, Thomas MB, Paz-Pabon C, Hernandez E.
    J Reprod Med; 2012 Mar; 57(9-10):411-4. PubMed ID: 23091988
    [Abstract] [Full Text] [Related]

  • 23. Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.
    Kwon JS, Elit L, Mazurka J, Moens F, Schmuck ML.
    Gynecol Oncol; 2001 Aug; 82(2):367-70. PubMed ID: 11531296
    [Abstract] [Full Text] [Related]

  • 24. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
    Lurain JR, Nejad B.
    Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
    [Abstract] [Full Text] [Related]

  • 25. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate.
    Gilani MM, Fariba B, Behtash N, Ghaemmaghami F, Moosavi AS, Rezayof E.
    J Cancer Res Ther; 2013 May; 9(1):38-43. PubMed ID: 23575072
    [Abstract] [Full Text] [Related]

  • 26. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia.
    Lybol C, Sweep FC, Harvey R, Mitchell H, Short D, Thomas CM, Ottevanger PB, Savage PM, Massuger LF, Seckl MJ.
    Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329
    [Abstract] [Full Text] [Related]

  • 27. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
    Chen LM, Lengyel ER, Bethan Powell C.
    Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
    [Abstract] [Full Text] [Related]

  • 28. What is the best protocol of single-agent methotrexate chemotherapy in nonmetastatic or low-risk metastatic gestational trophoblastic tumors? A review of the evidence.
    Foulmann K, Guastalla JP, Caminet N, Trillet-Lenoir V, Raudrant D, Golfier F, Schott AM.
    Gynecol Oncol; 2006 Jul; 102(1):103-10. PubMed ID: 16624388
    [Abstract] [Full Text] [Related]

  • 29. Vaginal metastases complicating gestational trophoblastic neoplasia.
    Cagayan MS.
    J Reprod Med; 2010 Jul; 55(5-6):229-35. PubMed ID: 20626179
    [Abstract] [Full Text] [Related]

  • 30. 5-day methotrexate for women with metastatic gestational trophoblastic disease.
    Soper JT, Clarke-Pearson DL, Berchuck A, Rodriguez G, Hammond CB.
    Gynecol Oncol; 1994 Jul; 54(1):76-9. PubMed ID: 8020843
    [Abstract] [Full Text] [Related]

  • 31. Treatment results of methotrexate and folinic acid as primary chemotherapy for nonmetastatic gestational trophoblastic neoplasia.
    Srisomboon J, Suprasert P, Phongnarisorn C, Charoenkwan K, Siriaree S, Cheewakriangkrai C, Tantipalakorn C, Kietpeerakool C.
    J Med Assoc Thai; 2005 Jul; 88(7):886-90. PubMed ID: 16241014
    [Abstract] [Full Text] [Related]

  • 32. Management of brain metastases in patients with high-risk gestational trophoblastic tumors.
    Newlands ES, Holden L, Seckl MJ, McNeish I, Strickland S, Rustin GJ.
    J Reprod Med; 2002 Jun; 47(6):465-71. PubMed ID: 12092015
    [Abstract] [Full Text] [Related]

  • 33. Practical issues in the management of low-risk gestational trophoblast tumors.
    Savage P, Seckl M, Short D.
    J Reprod Med; 2008 Oct; 53(10):774-80. PubMed ID: 19004403
    [Abstract] [Full Text] [Related]

  • 34. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
    Gilani MM, Yarandi F, Eftekhar Z, Hanjani P.
    Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of weekly intramuscular methotrexate in the treatment of low risk gestational trophoblastic neoplasia.
    Hasanzadeh M, Tabari A, Homae F, Shakeri M, Bakhshandeh T, MadaniSani F.
    J Cancer Res Ther; 2014 Apr; 10(3):646-50. PubMed ID: 25313754
    [Abstract] [Full Text] [Related]

  • 36. [Trophoblastic diseases].
    ten Kate-Booij MJ, Lok CA, Verheijen RH, Massuger LF, van Trommel NE.
    Ned Tijdschr Geneeskd; 2008 Oct 11; 152(41):2219-24. PubMed ID: 19009808
    [Abstract] [Full Text] [Related]

  • 37. Chemotherapy regimens used in the treatment of gestational trophoblastic neoplasia at Philippine General Hospital: treatment outcomes and toxicity.
    Cagayan MS, Gacoba MC.
    J Reprod Med; 2006 Nov 11; 51(11):907-18. PubMed ID: 17165439
    [Abstract] [Full Text] [Related]

  • 38. Treatment of nonmetastatic and metastatic low-risk gestational trophoblastic neoplasia: factors associated with resistance to single-agent methotrexate chemotherapy.
    Chapman-Davis E, Hoekstra AV, Rademaker AW, Schink JC, Lurain JR.
    Gynecol Oncol; 2012 Jun 11; 125(3):572-5. PubMed ID: 22449733
    [Abstract] [Full Text] [Related]

  • 39. Actinomycin D for methotrexate-failed low-risk gestational trophoblastic neoplasia.
    Lurain JR, Chapman-Davis E, Hoekstra AV, Schink JC.
    J Reprod Med; 2012 Jun 11; 57(7-8):283-7. PubMed ID: 22838241
    [Abstract] [Full Text] [Related]

  • 40. Safety and efficacy of systemic methotrexate in the treatment of unruptured tubal pregnancy.
    Soliman KB, Saleh NM, Omran AA.
    Saudi Med J; 2006 Jul 11; 27(7):1005-10. PubMed ID: 16830020
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.